B-lymphocyte antigen CD20 or CD20 is an activated-glycosylatedphosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity.
This gene encodes a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. This gene encodes a B-lymphocyte surface molecule that plays a role in the development and differentiation of B-cells into plasma cells. This family member is localized to 11q12, among a cluster of family members. Alternative splicing of this gene results in two transcript variants that encode the same protein.
The protein has no known natural ligand and its function is to enable optimal B-cell immune response, specifically against T-independent antigens. It is suspected that it acts as a calcium channel in the cell membrane.
Immunohistochemistry can be used to determine the presence of CD20 on cells in histological tissue sections. Because CD20 remains present on the cells of most B-cell neoplasms, and is absent on otherwise similar appearing T-cell neoplasms, it can be very useful in diagnosing conditions such as B-cell lymphomas and leukaemias. However, the presence or absence of CD20 in such tumours is not relevant to prognosis, with the progression of the disease being much the same in either case. CD20 positive cells are also sometimes found in cases of Hodgkins disease, myeloma, and thymoma.
Antibody FMC7 appears to recognise a conformational variant of CD20 also known as the FMC7 antigen.
A link between the immune system's B cells and diabetes mellitus has been determined. In cases of obesity, the presence of fatty tissues surrounding the body's major organ systems results in cell necrosis and insulin desensitivity along the boundary between them. Eventually, the contents of fat cells that would otherwise have been digested by insulin are shed into the bloodstream. An inflammation response that mobilizes both T and B cells results in the creation of antibodies against these cells, causing them to become less responsive to insulin by an as-yet unknown mechanism and promoting hypertension, hypertriglyceridemia, and arteriosclerosis, hallmarks of the metabolic syndrome. Obese mice administered anti-B cell CD-20 antibodies, however, did not become less responsive to insulin and as a result did not develop diabetes mellitus or the metabolic syndrome, the posited mechanism being that anti-CD20 antibodies rendered the T cell antibodies dysfunctional and therefore powerless to cause insulin desensitivity by a B cell antibody-modulated autoimmune response. The protection afforded by anti-CD-20 lasted approximately forty days—the time it takes the body to replenish its supply of B cells—after which repetition was necessary to restore it. Hence, it has been argued that obesity be reclassified as an autoimmune disease rather than a purely metabolic one and focus treatment for it on immune system modulation.
^Hardy, Richard (2008). "Chapter 7: B Lymphocyte Development and Biology". In Paul, William. Fundamental Immunology (Book) (6th ed.). Philadelphia: Lippincott Williams & Wilkins. pp. 237–269. ISBN0-7817-6519-6.
^Walport M, Murphy K, Janeway C, Travers PJ (2008). Janeway's Immunobiology (7th ed.). New York: Garland Science. ISBN0-8153-4123-7.
^Bonilla FA, Bona CA (1996). "5". Textbook of Immunology. Boca Raton: CRC. p. 102. ISBN3-7186-0596-1.
^Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M (October 2005). "A tumorigenic subpopulation with stem cell properties in melanomas". Cancer Res.65 (20): 9328–37. doi:10.1158/0008-5472.CAN-05-1343. PMID16230395.
^Cooper K, Anthony Leong AS-Y (2003). Manual of diagnostic antibodies for immunohistology (2nd ed.). London: Greenwich Medical Media. ISBN1-84110-100-1.
^Polyak MJ, Ayer LM, Szczepek AJ, Deans JP (July 2003). "A cholesterol-dependent CD20 epitope detected by the FMC7 antibody". Leukemia17 (7): 1384–9. doi:10.1038/sj.leu.2402978. PMID12835728.
^Serke S, Schwaner I, Yordanova M, Szczepek A, Huhn D (April 2001). "Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: evidence from phenotyping after rituxan therapy and transfectant cell analyses". Cytometry46 (2): 98–104. doi:10.1002/cyto.1071. PMID11309819.
Macardle PJ, Nicholson IC (2003). "CD20". J. Biol. Regul. Homeost. Agents16 (2): 136–8. PMID12144126.
Tamayose K, Sato N, Ando J; et al. (2002). "CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature". Am. J. Hematol.71 (4): 331–5. doi:10.1002/ajh.10224. PMID12447967.
Küster H, Zhang L, Brini AT; et al. (1992). "The gene and cDNA for the human high affinity immunoglobulin E receptor beta chain and expression of the complete human receptor". J. Biol. Chem.267 (18): 12782–7. PMID1535625.
Tedder TF, Disteche CM, Louie E; et al. (1989). "The gene that encodes the human CD20 (B1) differentiation antigen is located on chromosome 11 near the t(11;14)(q13;q32) translocation site". J. Immunol.142 (7): 2555–9. PMID2466898.
Tedder TF, Klejman G, Schlossman SF, Saito H (1989). "Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1)". J. Immunol.142 (7): 2560–8. PMID2466899.
Loken MR, Shah VO, Dattilio KL, Civin CI (1987). "Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development". Blood70 (5): 1316–24. PMID3117132.
Bofill M, Janossy G, Janossa M; et al. (1985). "Human B cell development. II. Subpopulations in the human fetus". J. Immunol.134 (3): 1531–8. PMID3871452.
Deans JP, Kalt L, Ledbetter JA; et al. (1995). "Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20". J. Biol. Chem.270 (38): 22632–8. doi:10.1074/jbc.270.38.22632. PMID7545683.
Valentine MA, Licciardi KA, Clark EA; et al. (1993). "Insulin regulates serine/threonine phosphorylation in activated human B lymphocytes". J. Immunol.150 (1): 96–105. PMID7678037.
Shirakawa T, Li A, Dubowitz M; et al. (1994). "Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor". Nat. Genet.7 (2): 125–9. doi:10.1038/ng0694-125. PMID7920628.
Szepetowski P, Perucca-Lostanlen D, Gaudray P (1993). "Mapping genes according to their amplification status in tumor cells: contribution to the map of 11q13". Genomics16 (3): 745–50. doi:10.1006/geno.1993.1257. PMID8325649.
Algino KM, Thomason RW, King DE; et al. (1996). "CD20 (pan-B cell antigen) expression on bone marrow-derived T cells". Am. J. Clin. Pathol.106 (1): 78–81. PMID8701937.
Szöllósi J, Horejsí V, Bene L; et al. (1996). "Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY". J. Immunol.157 (7): 2939–46. PMID8816400.
Kanzaki M, Lindorfer MA, Garrison JC, Kojima I (1997). "Activation of the calcium-permeable cation channel CD20 by alpha subunits of the Gi protein". J. Biol. Chem.272 (23): 14733–9. doi:10.1074/jbc.272.23.14733. PMID9169438.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.